FFA
NVAX icon

Farther Finance Advisors’s Novavax NVAX Stock Holding History

Farther Finance Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Buy
1,527
+417
+38% +$3.74K ﹤0.01% 4198
2026
Q1 		$8.9K Sell
1,110
-13,997
-93% -$127K ﹤0.01% 4186
2025
Q4 		$102K Sell
15,107
-10,414
-41% -$78.5K ﹤0.01% 2338
2025
Q3 		$221K Buy
25,521
+22,625
+781% +$176K ﹤0.01% 1553
2025
Q2 		$18.2K Buy
2,896
+1,937
+202% +$12.8K ﹤0.01% 2739
2025
Q1 		$5.75K Buy
959
+424
+79% +$3.5K ﹤0.01% 2991
2024
Q4 		$4.3K Sell
535
-100
-16% -$964 ﹤0.01% 2735
2024
Q3 		$8.02K Buy
635
+17
+3% +$220 ﹤0.01% 2454
2024
Q2 		$7.87K Sell
618
-240
-28% -$2.42K ﹤0.01% 2170
2024
Q1 		$3.99K Buy
858
+701
+446% +$3.25K ﹤0.01% 2171
2023
Q4 		$754 Buy
157
+117
+293% +$716 ﹤0.01% 2837
2023
Q3 		$290 Buy
40
+30
+300% +$240 ﹤0.01% 2392
2023
Q2 		$74 Sell
10
-2
-17% -$16 ﹤0.01% 2446
2023
Q1 		$83 Buy
12
+2
+20% +$18 ﹤0.01% 2294
2022
Q4 		$103 Buy
+10
New +$176 ﹤0.01% 2133

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Farther Finance Advisors's NVAX Position: Q2 2026 in Review

Farther Finance Advisors increased its Novavax (NVAX) stake by 38% in Q2 2026, buying an estimated $3.74K and bringing the position to 1,527 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4198.

Farther Finance Advisors first reported a position in NVAX in Q4 2022 and has held it in 15 quarters since. The position peaked at $221K in Q3 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Farther Finance Advisors held 1,527 shares of Novavax worth $14.4K as of Q2 2026.
  • Farther Finance Advisors bought 417 Novavax shares in Q2 2026, an estimated $3.74K.
  • Novavax made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4198 holding.
  • Farther Finance Advisors first reported a position in Novavax in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Novavax position peaked at $221K in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.